@rtogfoundation.bsky.social
We are very interested to learn more about this topic in radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/lzBs50Y0fUJ
February 2, 2026 at 2:00 PM
We are very interested to learn more about this topic in radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/lzBs50Y0fUJ
Did you know more information on the recently opened RTOG 3523 trial for progressive intracranial grade 1-3 meningioma is available on our website? Protocol documents are also available behind the login. https://www.rtog.org/Clinical-Trials/Foundation-Studies/3523
January 30, 2026 at 3:42 PM
Did you know more information on the recently opened RTOG 3523 trial for progressive intracranial grade 1-3 meningioma is available on our website? Protocol documents are also available behind the login. https://www.rtog.org/Clinical-Trials/Foundation-Studies/3523
ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8
January 26, 2026 at 12:00 PM
ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8
NRG-BN001, NRG-GU005, NRG-GU006... all featured in the #NRG2026 Scientific Session today! Stop by to hear about these results and more at 3:00PM PT.
January 23, 2026 at 9:00 PM
NRG-BN001, NRG-GU005, NRG-GU006... all featured in the #NRG2026 Scientific Session today! Stop by to hear about these results and more at 3:00PM PT.
The #NRG2026 General Session is a great opportunity to hear the many updates coming out of the NRG committees and centers. Stop by this session at 12PM PT today.
January 23, 2026 at 5:00 PM
The #NRG2026 General Session is a great opportunity to hear the many updates coming out of the NRG committees and centers. Stop by this session at 12PM PT today.
We are SO thankful for our wonderful RTOG Foundation Communications Interns and all they are doing on the ground at #NRG2026! From video interviews, social media coverage, and more. We are lucky to have them.
January 22, 2026 at 8:01 PM
We are SO thankful for our wonderful RTOG Foundation Communications Interns and all they are doing on the ground at #NRG2026! From video interviews, social media coverage, and more. We are lucky to have them.
TONIGHT at #NRG2026 in San Francisco join us for updates on our Foundation plus networking with refreshments. We'll be in the Hilton San Francisco Union Square Plaza B. Doors open at 6:45pm and presentations start at 7pm.
January 22, 2026 at 4:01 PM
TONIGHT at #NRG2026 in San Francisco join us for updates on our Foundation plus networking with refreshments. We'll be in the Hilton San Francisco Union Square Plaza B. Doors open at 6:45pm and presentations start at 7pm.
We are very interested to learn more about this topic in radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/lzBs50Y0fUJ
January 21, 2026 at 12:01 PM
We are very interested to learn more about this topic in radiation-associated chest wall sarcomas! SSO and NRG are jointly hosting a webinar on February 19th. Register here: https://ow.ly/lzBs50Y0fUJ
Starting at 1PM ET today! Learn about digital engagement and the impact it makes in clinical research from both the patient and physician perspectives (Registration required via #NRG2026). More info on NRG Meeting virtual sessions: https://ow.ly/AlM250Y0fum
January 20, 2026 at 5:33 PM
Starting at 1PM ET today! Learn about digital engagement and the impact it makes in clinical research from both the patient and physician perspectives (Registration required via #NRG2026). More info on NRG Meeting virtual sessions: https://ow.ly/AlM250Y0fum
ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8
January 16, 2026 at 12:00 PM
ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8
PUB ALERT: Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40829719/
January 13, 2026 at 3:22 PM
PUB ALERT: Self-Perceived Hearing Outcomes With Radiation and Cisplatin or Radiation and Cetuximab for Patients With Human Papilloma Virus (HPV)-Positive Oropharyngeal Cancer-Results From NRG Oncology RTOG 1016 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40829719/
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41436315/
January 10, 2026 at 1:00 PM
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41436315/
Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting in Plaza B. Come by to network & hear updates on what RTOGF has been up to this year. @NRGOnc
January 9, 2026 at 1:00 PM
Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting in Plaza B. Come by to network & hear updates on what RTOGF has been up to this year. @NRGOnc
ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8
January 8, 2026 at 1:01 PM
ACR will be hosting its quarterly Radiation Oncology Education Webinar on February 10th from 5-6pm ET! This edition is on ABR Radiation Oncology Board Certifying Exam Updates. Attendees of this webinar receive 1 CME credit. Register: https://ow.ly/70PC50XTlR8
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40752652/
January 5, 2026 at 5:30 PM
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Long-term Follow-up of NRG Oncology RTOG 9911 - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40752652/
We look forward to all we can build together and the changes we can make through our research together in 2026. Have a happy and safe holiday. RTOG Foundation will reopen tomorrow, January 2nd.
January 1, 2026 at 3:01 PM
We look forward to all we can build together and the changes we can make through our research together in 2026. Have a happy and safe holiday. RTOG Foundation will reopen tomorrow, January 2nd.
Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting. Come by to network & hear updates on what RTOGF has been up to this year.
December 26, 2025 at 5:00 PM
Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting. Come by to network & hear updates on what RTOGF has been up to this year.
We want to wish everyone a happy and safe holiday season. This is a reminder that we will be closed starting today, December 24th at 12pm ET. We will reopen on January 2nd. Please note that we will have limited staff available during this time.
December 24, 2025 at 1:00 PM
We want to wish everyone a happy and safe holiday season. This is a reminder that we will be closed starting today, December 24th at 12pm ET. We will reopen on January 2nd. Please note that we will have limited staff available during this time.
PUB ALERT: Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41343184/
December 22, 2025 at 2:02 PM
PUB ALERT: Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41343184/
With the holiday season, fast approaching we want to acknowledge our upcoming office closures. We will be closed starting December 24th at 12pm ET. We will reopen on January 2nd. Please note that we will have limited staff available during this time.
December 19, 2025 at 1:01 PM
With the holiday season, fast approaching we want to acknowledge our upcoming office closures. We will be closed starting December 24th at 12pm ET. We will reopen on January 2nd. Please note that we will have limited staff available during this time.
PUB ALERT: Phase 3 Trial of Dose-Escalated RT & Standard Androgen Deprivation Therapy Versus Dose-Escalated RT and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115) - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41189315/
December 10, 2025 at 4:37 PM
PUB ALERT: Phase 3 Trial of Dose-Escalated RT & Standard Androgen Deprivation Therapy Versus Dose-Escalated RT and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115) - PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41189315/
Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting. Come by to network & hear updates on what RTOGF has been up to this year.
December 9, 2025 at 6:48 PM
Are you attending #NRG2026 in San Fran? We cannot wait to check out the amazing sessions available. Mark your calendars for Thursday evening: RTOGF will be hosting our annual Investigators Meeting. Come by to network & hear updates on what RTOGF has been up to this year.
Did You Know? There are several ways you can participate in RTOG Foundation as a member site, an industry collaborator, or by enrolling in one of our studies. Read more on our website about how you can partner with RTOG Foundation. Learn more at http://RTOG.org/Partners
December 8, 2025 at 2:38 PM
Did You Know? There are several ways you can participate in RTOG Foundation as a member site, an industry collaborator, or by enrolling in one of our studies. Read more on our website about how you can partner with RTOG Foundation. Learn more at http://RTOG.org/Partners
RTOG 3521, also known as the "TRANSPARENT" study, is evaluating the role of combo chemo-immunotherapy in patients w/ #NasopharyngealCancer - Study information is available on our website as well as study documents (behind login): https://www.rtog.org/Clinical-Trials/Foundation-Studies/3521
December 5, 2025 at 1:01 PM
RTOG 3521, also known as the "TRANSPARENT" study, is evaluating the role of combo chemo-immunotherapy in patients w/ #NasopharyngealCancer - Study information is available on our website as well as study documents (behind login): https://www.rtog.org/Clinical-Trials/Foundation-Studies/3521